Xenotransplant Record

A donor heart from a genetically modified pig survives for more than 2.5 years inside a baboon’s abdomen.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, TITANIUM22Scientists have made an important stride toward pig-to-human xenotransplants: a heart from a genetically modified pig implanted in a baboon has survived for more than 2.5 years, thanks to a cocktail of anti-rejection drugs, researchers at the US National Institutes of Health reported yesterday (April 5) in Nature Communications. The researchers previously reported a survival record of 500 days for such a transplant.

“Xenotransplants—organ transplants between different species—could potentially save thousands of lives each year that are lost due to a shortage of human organs for transplantation,” study coauthor Muhammad Mohiuddin, a transplant surgeon at the National Heart, Lung, and Blood Institute, told the Agence France-Presse.

Previous efforts failed because the recipient’s immune system rejected the organs. To overcome this, Mohiuddin and colleagues used organs from knockout pigs that lacked the galactosyltransferase gene. This gene produces the human proteins CD46 and thrombomodulin, which prevent immune rejection and blood clotting, respectively.

The researchers transplanted the pig hearts into the abdomens of five baboons, and then treated the animals with a cocktail of anti-rejection drugs and antibodies, The Washington Post reported. The addtional, donor hearts survived for a median of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tanya Lewis

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development